F01 in the Treatment of Relapsed/Refractory Non-hodgkin's Lymphoma

NCT06206902 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

55

Enrollment

INDUSTRY

Sponsor class

Conditions

Non-Hodgkin's Lymphoma

Interventions

DRUG: After preconditioning with chemotherapy, F01 will be evaluated.

Sponsor

Shanghai Simnova Biotechnology Co.,Ltd.

Collaborators

[object Object]